Anti-programmed cell death-1 therapy in octogenarian and nonagenarian advanced/metastatic melanoma patients

ola Kala shared this article with you from Inoreader Anti-programmed cell death-1 therapy in octogenarian and nonagenarian advanced/metastatic melanoma patients Μέσω Melanoma Research - Current Issue Immunotherapy with anti-programmed cell death-1 (PD-1) agents is an effective treatment for metastatic melanoma. Octogenarians and nonagenarians represent a significant cohort of melanoma patients. This multicenter retrospective analysis enrolled 499 patients treated with nivolumab or pembrolizumab. Seventy-three patients were aged 80–100, 218 patients were aged 65–79, and 208 patients were View on the web Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.